Cargando…

A new concept in NF2 pharmacotherapy: targeting fatty acid synthesis

Detalles Bibliográficos
Autores principales:	Stepanova, Dina S., Braun, Lanita, Chernoff, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049319/ https://www.ncbi.nlm.nih.gov/pubmed/30035161 http://dx.doi.org/10.18632/oncoscience.417

Ejemplares similares

p21-Activated Kinases Are Required for Transformation in a Cell-Based Model of Neurofibromatosis Type 2
por: Chow, Hoi Yee, et al.
Publicado: (2010)

A New Landscape for Systemic Pharmacotherapy of Recurrent Glioblastoma?
por: Lombardi, Giuseppe, et al.
Publicado: (2020)

The examination of geriatric pharmacotherapy
por: Farinde, Abimbola
Publicado: (2013)

Non-Compliance in Pharmacotherapy
por: Reddy, M. S.
Publicado: (2012)

Pharmacotherapy of pediatric metabolic syndrome
por: Kelishadi, Roya, et al.
Publicado: (2013)

Obesity Treatment – Is Pharmacotherapy the Answer?
por: Rangbulla, Aditya Kumar
Publicado: (2020)

Potential pharmacotherapy for Zinner syndrome
por: Takeshima, Teppei
Publicado: (2023)

Pharmacotherapy of post-traumatic stress disorder: going beyond the guidelines
por: Davidson, Jonathan
Publicado: (2016)

Editorial for the Special Issue “New Strategies in Cancer Pharmacotherapy: Development of Hormonal Antineoplastic Drugs, Cytotoxic Drugs and Targeted Therapies”
por: Martínez-Campa, Carlos, et al.
Publicado: (2020)

Pharmacotherapy for Age-Related Macular Degeneration
por: Ahmadieh, Hamid
Publicado: (2008)

Pharmacotherapy during Pregnancy, Childbirth, and Lactation
por: Allegaert, Karel
Publicado: (2022)

Targeting Group I p21-Activated Kinases to Control Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
por: Semenova, Galina, et al.
Publicado: (2017)

Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies
por: Strykowski, Rachel, et al.
Publicado: (2021)

Fatty acid synthesis and NLRP3-inflammasome
por: Moon, Jong-Seok, et al.
Publicado: (2015)

Are we over-dependent on pharmacotherapy?
por: Kallivayalil, Roy Abraham
Publicado: (2008)

Orexin Receptor Competitive Antagonists: A Novel target of the Sedative and hypnotics drugs for the pharmacotherapy of Insomnia
por: Banerjee, Indrajit
Publicado: (2018)

Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates
por: Prikhodko, Veronika A., et al.
Publicado: (2022)

Pharmacotherapy for Gastroparesis: An Attempt to Evaluate a Safer Alternative
por: Ghoshal, Uday C
Publicado: (2010)

Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome
por: Yin, Jun, et al.
Publicado: (2018)

Quest for pharmacotherapy in aortic valve stenosis: the lipid hypothesis
por: Zheng, Kang H, et al.
Publicado: (2020)

Pharmacotherapy of the Lipid-Lowering Drugs: Update on Efficacy and Risk
por: Pierno, Sabata, et al.
Publicado: (2023)

Short-term mechanical support and pharmacotherapy, a new strategy in cardiogenic shock?
por: Tseng, C. C. S., et al.
Publicado: (2014)

The hope for targeting fatty acid binding proteins in multiple myeloma
por: Fairfield, Heather, et al.
Publicado: (2023)

Pharmacotherapy for acid/peptic disorders.
por: Schubert, M. L.
Publicado: (1996)

Targeting Asporin in Lung Fibrosis: A New Approach to an Old Concept
por: He, Chao, et al.
Publicado: (2021)

Pharmacotherapy for Acute Respiratory Distress Syndrome: Limited Success to Date
por: Jeon, Kyeongman
Publicado: (2017)

Introduction to the Special Section: COVID-19 - insights on pharmacology and pharmacotherapy
por: Sanak, Marek
Publicado: (2020)

Choosing the appropriate pharmacotherapy for nonspecific chronic low back pain
por: Migliorini, Filippo, et al.
Publicado: (2022)

Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy
por: Wang, David, et al.
Publicado: (2023)

Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2)
por: Shen, Yu-chi, et al.
Publicado: (2019)

New Conceptions in Malaria
Publicado: (1926)

New Conceptions in Amœbiasis
Publicado: (1926)

Targeting NFκB signaling in GD2(+) BCSCs
por: Nguyen, Khoa, et al.
Publicado: (2017)

Positioning new pharmacotherapies for COPD
por: Barjaktarevic, Igor Z, et al.
Publicado: (2015)

Biomarkers, population-based studies and a proof of principle investigation in pharmacotherapy
por: Falkai, P., et al.
Publicado: (2010)

The functional sequelae of schizophrenia: consequences of long-term pharmacotherapy and the neurobiology of addiction
por: Falkai, P., et al.
Publicado: (2011)

Knowledge driven pharmacotherapy in neonates: A perinatal research agenda is needed
por: Allegaert, Karel
Publicado: (2014)

Pharmacotherapy of Obstructive Sleep Apnea: Is Salvation Just Around a Corner?
por: Fleury Curado, Thomaz, et al.
Publicado: (2019)

Group I Paks as therapeutic targets in NF2-deficient meningioma
por: Chow, Hoi-Yee, et al.
Publicado: (2015)

Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents
por: Stepanova, Ekaterina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6a130fnjau03ngljjemask1aha